Advances and Controversies in Military Posttraumatic Stress Disorder Screening

被引：0
作者：
Daniel J. Lee
Christopher H. Warner
Charles W. Hoge
机构：
[1] Bayne-Jones Army Community Hospital,Department of Behavioral Health
[2] 101st Airborne Division,Center of Psychiatry & Neuroscience
[3] Walter Reed Army Institute of Research,undefined
来源：
Current Psychiatry Reports | 2014年 / 16卷
关键词：
PTSD; Posttraumatic stress disorder; Screening; Epidemiology; Force screening; US military; Readiness; Deployment; Combat; Prevalence; Positive predictive value; Negative predictive value; Sensitivity; Specificity; DoD; VA; NDAA; CAPS; SPRINT; DTS; PCL; PTSD Checklist; Davidson Trauma Scale;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
As the longest war in American history draws to a close, an unprecedented number of service members and veterans are seeking care for health challenges related to transitioning home and to civilian life. Congressionally mandated screening for mental health concerns in the Department of Defense (DoD), as well as screening efforts Veterans Affairs (VA) facilities, has been established with the goal of decreasing stigma and ensuring service members and veterans with depression and posttraumatic stress disorder (PTSD) receive needed treatment. Both the DoD and VA have also developed integrated behavioral health in primary-care based initiatives, which emphasize PTSD screening, treatment, and care coordination. This article discusses the rationale for population-level deployment-related mental health screening, recent changes to screening frequency, commonly used screening instruments such as the primary care PTSD screen (PC-PTSD), PTSD checklist (PCL), and Davidson Trauma Scale (DTS); as well as the strengths/limitations of each, and recommended cut-off scores based on expected PTSD prevalence.
引用
收藏
相关论文
共 203 条
[11]  
Auchterlonie J(2002)Fluoxetine Versus Placebo in Posttraumatic Stress Disorder J Clin Psychiatry 16 340-9
[12]  
Hoge C(2006)Fluoxetine in the acute treatment and relapse prevention of combat-related post-traumatic stress disorder: Analysis of the veteran group of a placebo-controlled, randomized clinical trial Eur Neuropsychopharmacol 160 371-3
[13]  
Warner C(2003)Reduction of Nightmares and Other PTSD Symptoms in Combat Veterans by Prazosin: A Placebo-Controlled Study Am J Psychiatry 170 1003-10
[14]  
Appenzeller G(2013)A Trial of Prazosin for Combat Trauma PTSD With Nightmares in Active-Duty Soldiers Returned From Iraq and Afghanistan Am J Psychiatry 169 80-8
[15]  
Grieger T(2012)Combined Prolonged Exposure Therapy and Paroxetine for PTSD Related to the World Trade Center Attack: A Randomized Controlled Trial Am J Psychiatry 155 630-7
[16]  
Belenkiy S(1998)Prospective Study of Posttraumatic Stress Disorder and Depression Following Trauma Am J Psychiatry 69 1560-6
[17]  
Breitbach J(2010)Prevalence of PTSD and Major Depression Following Trauma-Center Hospitalization J Trauma 68 37-46
[18]  
Hoge C(2007)A Randomized Clinical Trial of Eye Movement Desensitization and Reprocessing (EMDR), Fluoxetine, and Pill Placebo in the Treatment of Posttraumatic Stress Disorder: Treatment Effects and Long-Term Maintenance J Clin Psychiatry 164 150-3
[19]  
Auchterlonie J(2007)Association of Posttraumatic Stress Disorder With Somatic Symptoms, Health Care Visits, and Absenteeism Among Iraq War Veterans Am J Psychiatry 41 79-84
[20]  
Milliken C(2013)Combat-Related Posttraumatic Stress Disorder and Criminal Responsibility Determinations in the Post-Iraq Era: A Review and Case Report J Am Acad Psychiatry Law 21 290-300
12345678910